Opportunities and challenges in oncology targeted drug development : an assessment of the use of prevalence and companion diagnostic performance thresholds to guide clinical trial strategies
Thesis (S.M. in Health Sciences and Technology)--Harvard-MIT Program in Health Sciences and Technology, 2012.
Main Author: | Vital, Heather Stacey Tomkinson |
---|---|
Other Authors: | Ernst R. Berndt and Keith T. Flaherty. |
Format: | Thesis |
Language: | eng |
Published: |
Massachusetts Institute of Technology
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/78156 |
Similar Items
-
Pricing and reimbursement challenges for fixed dose combination cardiovascular drugs and intravenous oncologies
by: Cronin-Fine, Drew
Published: (2012) -
Assessment of the appropriateness and market opportunity of a point-of-care diagnostic solution for hepatitis C in the United States
by: Rocker, Charlotte (Charlotte Amanda Lucy)
Published: (2012) -
Fulfilling the promise of targeted therapeutics in oncology via companion diagnostics : a perspective on pipeline trends and co-development strategies
by: Mehrotra, Anand
Published: (2012) -
Advanced optical microscopy toolkits for non-invasive imaging in oncology
by: Osseiran, Sam
Published: (2019) -
Drug eluting prosthetic joints through drug cluster morphology control
by: Suhardi, Vincentius Jeremy
Published: (2017)